Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia

20/01/2020


 

  • Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19
  • Medichem´s DMF for Quetiapine´s Active Pharmaceutical Ingredient is filed to the NMPA, China – Q4′ 19